Kibow Biotech, Inc. – Trademark Portfolio
Entity Type: 03
Kibow Biotech, Inc. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include KIBOW, KIBOW FORTIS, ENTERIC DIALYSIS, and INTESTINAL DIALYSIS. The owner is based in Newtown Square, PA.
4781 West Chester Pike
Newtown Square, PA 19073
Showing of trademarks Trademarks
Trademark Classifications
Kibow Biotech, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Kibow Biotech, Inc. have?
Kibow Biotech, Inc. has 14 U.S. trademarks filed with the USPTO. Of these, 4 registered, 8 abandoned, 2 cancelled.
What trademark classes does Kibow Biotech, Inc. file in?
Kibow Biotech, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Kibow Biotech, Inc.'s most well-known trademarks?
Kibow Biotech, Inc.'s registered trademark portfolio includes well-known marks such as KIBOW, KIBOW FORTIS, ENTERIC DIALYSIS, and INTESTINAL DIALYSIS. These are among 4 currently registered trademarks in the portfolio.
What is Kibow Biotech, Inc.'s trademark registration success rate?
Kibow Biotech, Inc. has a 29% trademark registration rate, with 4 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.